Mumbai, July 7 -- Biocon Biologics announced that the Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorisations in the United Kingdom (UK) for Vevzuo(R) and Evfraxy(R), biosimilars of Denosumab.
Published by HT Digital Content Services with permission from Capital Market....